Quantcast
Channel: Safety and Quality
Viewing all articles
Browse latest Browse all 170

National Standard Hospital-Level Cumulative Antibiogram Expert Roundtable, 11 December 2012

$
0
0

Purpose

The Expert Roundtable was convened to introduce the Commission’s proposal on the hospital-level cumulative antibiogram, and to understand current approaches to monitoring antimicrobial resistance

Cumulative Antibiogram Expert Roundtable Agenda 11 December 2012 (PDF 40KB)

 Presentations

1.      Overview of AMR and AMS in Australia, Dr Marilyn Cruickshank, Australian Commission on Safety and Quality in Healthcare (PDF 2.6MB)

2.      Site Presentation Hunter New England Local Health District, Dr Patrick Harris (PDF 1MB)

3.      Site Presentation Centre for Queensland Health Related Infection Surveillance and Prevention (CHRISP), Ms Louise Davis (PDF 612KB)

4.      Site Presentation South Australia Department of Health, Dr Morgyn Warner (PDF 670kb)

5.      Sullivan Nicolaides Pathology, Dr Jenny Robson (PDF 613KB)

6.      Analysis of current cumulative antibiograms, Ms Siobhan McFadden, Australian Commission on Safety and Quality in Healthcare (PDF 450KB)

Outcomes

It was agreed that 6-7 members from the expert roundtable would volunteer to be on the working group to help draft the national standard hospital-level cumulative antibiogram ‘straw man’. The tasks for the working group are:

  •  To draft a standard format for a minimum hospital level cumulative antibiogram for bacteria, suitable for a hospital which does not currently produce such a document.
  • The draft standard format should be:
    • Appropriate for use by a hospital’s antimicrobial stewardship team to determine antibiotic policy for that hospital. It is not intended to provide it to a wider audience.
    • Consistent with the CLSI guidelines.
    • Consist of data from all wards of the hospital, including out patients & emergency.
    • It should provide a list of bacteria and a list of antimicrobials to be reported for each.
  • For hospitals with small numbers of isolates, the draft standard should provide rules for accumulating numbers e.g. by reporting by genus rather than species.
  • If  a bacterial species/genus’  susceptibility is tested against certain antibiotics only if it is resistant to first-line antibiotics, then it should be clear what number of isolates were tested against these antibiotics.
  • The format will include standardised advice on commentary, which will be an intrinsic component of the antibiogram. The commentary may include colour coding or symbols.
  • Results must be stratified by patient age groups.

Viewing all articles
Browse latest Browse all 170

Trending Articles